BRIEF published on 10/24/2024 at 06:50, 28 days 6 hours ago Galenica Reports Robust Sales Growth in Third Quarter Sales Growth Pharmaceutical Market Galenica AG Generics And Biosimilars Logistics & IT
PRESS RELEASE published on 10/24/2024 at 06:45, 28 days 6 hours ago Galenica increases sales growth in the third quarter Galenica reports 4.1% sales growth in the third quarter of 2024, outperforming the pharmaceutical market. Confirms sales growth outlook for 2024 2024 Outlook Sales Growth Galenica Pharmaceutical Market Third Quarter
BRIEF published on 08/06/2024 at 07:05, 3 months 15 days ago Expansion of management and handover to the position of CFO at Galenica CFO Reorganization Strategy Galenica Pharmacies
PRESS RELEASE published on 08/06/2024 at 07:00, 3 months 15 days ago Expansion of the Executive Committee and handover of the position of CFO Galenica restructures its executive team to enhance customer focus. CFO Felix Burkhard to step down by end of 2024, Julian Fiessinger to take over. Strategic aims include growth and improved customer satisfaction CFO Restructuring Growth Galenica Customer Focus
BRIEF published on 08/06/2024 at 06:50, 3 months 15 days ago Galenica Reports Solid Growth Amid Challenging Market Conditions Sales Growth Galenica IT Infrastructure Pharmacy Market Generic Medicines
PRESS RELEASE published on 08/06/2024 at 06:45, 3 months 15 days ago Galenica achieves solid growth in a challenging market environment Galenica achieves solid growth in the first half of 2024 with 2.6% sales increase, confirming 2024 guidance. 10.7% EBIT growth seen, with various successes in healthcare services and market expansion Sales Growth Market Expansion Galenica EBIT Increase Healthcare Services
BRIEF published on 07/22/2024 at 18:16, 3 months 29 days ago Galenica Increases Stake in Redcare Pharmacy to 10% Investment Shareholding Redcare Pharmacy Galenica Pharmacy
PRESS RELEASE published on 07/22/2024 at 18:11, 3 months 29 days ago Galenica increases shareholding in Redcare Pharmacy to 10% Galenica increases stake in Redcare Pharmacy to 10% as part of strategic partnership, aiming for long-term investment benefits Strategic Partnership Investment Redcare Pharmacy Online Pharmacy Galenica
BRIEF published on 05/23/2024 at 06:50, 5 months 29 days ago Galenica stays the course with sales growth Pharmaceutical Growth Turnover Galenica Generics
PRESS RELEASE published on 05/23/2024 at 06:45, 5 months 29 days ago Galenica on track with sales growth Galenica Group reports 4.8% sales growth in the first four months of 2024, driven by positive pharmaceutical market development. Outlook for 2024 confirmed with sales growth between 3% and 5% Sales Growth Outlook 2024 Galenica Group Pharmaceutical Market
Published on 11/21/2024 at 13:00, 29 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 29 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 29 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 29 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 29 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 54 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 14 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 31 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 9 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 44 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 44 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
